Publication Cover
Nutritional Neuroscience
An International Journal on Nutrition, Diet and Nervous System
Volume 6, 2003 - Issue 3
106
Views
102
CrossRef citations to date
0
Altmetric
Articles

Lipoprotein Oxidation, Plasma Total Antioxidant Capacity and Homocysteine Level in Patients with Multiple Sclerosis

&
Pages 189-196 | Published online: 05 Sep 2013

References

  • Allain, C.C., Poon, L.S., Chan, C.S.G., Richmond, W. and Fu, P.C. (1974 ) “Enzymatic determination of total serum cholesterol”, Clinical Chemistry 20, 470–475.
  • Arlt, S., Kontush, A., Zerr, I., Buhmann, C., Jacobi, C., Schroter, A., Poser, S. and Beisiegel, U. (2002 ) “Increased lipid peroxidation in cerebrospinal fluid and plasma from patients with Creutzfeldt-Jakob disease”, Neurobiology of Disease 10, 150–156.
  • Beal, M.F., Swartz, K.J., Finn, S.F., Mazurek, M.F. and Kowall, N.W. (1991 ) “Neurochemical characterization of excitoxin lesions in the cerebral cortex”, Journal of Neuroscience 11, 147–158.
  • Besler, H.T., Comoglu, S. and Okcu, Z. (2002 ) “Serum levels of antioxidant vitamins and lipid peroxidation in multiple sclerosis”, Nutritional Neuroscience 5, 215–220.
  • Bö, L., Dawson, T.M., Wessenligh, S., Mörk, S., Choi, S., Kong, P.A., Hanley, D. and Trapp, B.D. (1994 ) “Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains”, Annals of Neurology 36, 778–786.
  • Bottiglieri, T. (1996 ) “Folate, vitamin B12, and neuropsychiatric disorders”, Nutrition Reviews 54, 382–390.
  • Bush, A.I. (2000 ) “Metals and neuroscience”, Current Opinion in Chemical Biology 4, 184–191.
  • Calabrase, V., Bates, T.E. and Stella, A.M.G. (2000 ) “NO synthase and NO-dependent signal pathways in brain aging and neurodegenerative disorders: the role of oxidant/antioxidant balance”, Neurochemical Research 25, 1315–1341.
  • Chan, S.-J., Chang, C.-N., Hsu, J.-C., Lee, Y.-S. and Shen, C.-H. (2002 ) “Homocysteine, vitamin B6, and lipid in cardiovascular disease”, Nutrition 18, 595–598.
  • Diaz-Arrastia, R. (2000 ) “Homocysteine and neurologic disease”, Archives of Neurology 57, 1422–1428.
  • Dudman, N.P.B., Guo, X.W., Crooks, R., Xie, L. and Silberberg, J.S. (1996 ) “Assay of plasma homocysteine: light sensitivity of the fluorescent 7-benzo-2-oxa-1,3-diazole-4-sulfonic acid derivative, and use of appropriate calibrators”, Clinical Chemistry 42, 2028–2032.
  • Esterbauer, H., Striegl, G., Puhl, H. and Rotheneder, M. (1989 ) “Continuous monitoring of in vitro oxidation of human low density lipoprotein”, Free Radical Research and Communication 6, 67–75.
  • Frei, B. and Gaziano, J.M. (1993 ) “Content of antioxidants, preformed lipid hydroperoxides, and cholesterol as predictors of the susceptibility of human LDL to metal ion- dependent and -independent oxidation”, Journal of Lipid Research 34, 2135–2145.
  • Friedewald, W.T., Levy, R.I. and Fredrickson, D.S. (1972 ) “Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge”, Clinical Chemistry 18, 499–502.
  • Gey, K.F. (1998 ) “Vitamins E plus C and interacting conutrients required for optimal health”, BioFactors 7, 113–174.
  • Ghiselli, A., Serafini, M., Natella, F. and Scaccini, C. (2000 ) “Total antioxidant capacity as a tool to assess redox status: critical view and experimental data”, Free Radical Biology and Medicine 29, 1106–1114.
  • Halliwell, B. and Gutteridge, J.M.C. (2001) Free Radicals in Biology and Medicine (Oxford University Press, New York, NY).
  • Hunter, M.I., Nlemadim, B.C. and Davidson, D.L. (1985 ) “Lipid peroxidation products and antioxidant proteins in plasma and cerebrospinal fluid from multiple sclerosis patients”, Neurochemical Research 10, 1645–1652.
  • Jackson, M.J., Papa, S., Bolanos, J., Bruckdorfer, R., Carlsen, H., Elliott, R.M., Flier, J., Griffiths, H.R., Heales, S., Holst, B., Lorusso, M., Lund, E., Moskaug, J.O., Moser, U., Di Paola, M., Polidori, M.C., Signorile, A., Stahl, W., Vina-Ribes, J. and Astley, S.B. (2002 ) “Antioxidants, reactive oxygen and nitrogen species, gene induction and mitochondrial function”, Molecular Aspects of Medicine 23, 209–285.
  • Kontush, A. and Beisiegel, U. (1999 ) “Measurement of oxidizability of blood plasma”, Methods in Enzymology 299, 35–49.
  • Kontush, A., Hubner, C., Finckh, B., Kohlschutter, A. and Beisiegel, U. (1996 ) “How different constituents of low density lipoprotein determine its oxidizability by copper: a correlational approach”, Free Radical Research 24, 135–147.
  • Lenz, M.L., Hughes, H., Mitchell, J.R., Via, D.P., Guyton, J.R., Taylor, A.A., Gotto, A.M. and Smith, C.V. (1990 ) “Lipid hydroperoxy andhydroxy derivatives in copper-catalyzed oxidation of low density lipoprotein”, Journal of Lipid Research 31, 1043–1050.
  • Lipton, S.A., Kim, W.K., Choi, Y.B., Kumar, S., D’Emilia, D.M., Rayuda, P.V., Arnelle, D.R. and Stamler, J.S. (1997 ) “Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor”, Proceedings of the National Academy of Sciences of the United States of America 94, 5923–5928.
  • Miller, N.J., Rice-Evans, C., Davies, M.J., Gopinathan, V. and Milner, A.A. (1993 ) “A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates”, Clinical Science 84, 407–412.
  • Mohr, D. and Stocker, R. (1994 ) “Radical-mediated oxidation of isolated human very-low-density lipoprotein”, Arteriosclerosis and Thrombosis 14, 1186–1192.
  • Naruszewicz, M., Klinke, M., Dziewanowski, K., Staniewicz, A. and Bukowska, H. (2001 ) “Homocysteine, fibrinogen, and lipoprotein (a) levels are simultaneously reduced in patients with chronic renal failure treated with folic acid, pyridoxine, and cyanocobalamin”, Metabolism 50, 131–134.
  • Nijst, T.Q., Wevers, R.A., Schoonderwaldt, H.C., Hommes, O.R. and de Haan, A.F. (1990 ) “Vitamin B12 and folate concentrations in serum and cerebrospinal fluid of neurological patients with special reference to multiple sclerosis and dementia”, Journal of Neurology, Neurosurgery, and Psychiatry 53, 951–954.
  • Noseworthy, J.H., Lucchinetti, C., Rodriguez, M. and Weinshenker, B.G. (2000 ) “Multiple Sclerosis”, The New England Journal of Medicine 343, 938–952.
  • Parthasarathy, S., Barnett, J. and Fong, L.G. (1990 ) “High-density lipoprotein inhibits the oxidative modification of low density lipoprotein”, Biochimica et Biophysica Acta 22, 275–283.
  • Poser, C.M., Paty, D.W. and Scheinberg, L. (1983 ) “New diagnostics criteria for multiple sclerosis: guideliness for research protocols”, Annals of Neurology 13, 227–231.
  • Regnström, J., Strom, K., Moldeus, P. and Nilsson, J. (1993 ) “Analysis of lipoprotein diene formation in human serum exposed to copper”, Free Radical Research and Communication 19, 267–278.
  • Reynolds, E.H., Linnell, J.C. and Faludy, J.E. (1991 ) “Multiple sclerosis associated with vitamin B12 deficiency”, Archives of Neurology 48, 808–811.
  • Reynolds, E.H., Bottiglieri, T., Laundy, M., Crellin, R.F. and Kirker, S.G. (1992 ) “Vitamin B12 metabolism in multiple sclerosis”, Archives of Neurology 49, 649–653.
  • Rifai, N., Cole, T.G., Ianotti, E., Law, T., Macke, M., Miller, R., Dowd, D. and Wiebe, D.A. (1998 ) “Assessment of interlaboratory performance in external proficiency testing programs with a direct HDL-cholesterol assay”, Clinical Chemistry 44, 1452–1458.
  • Rio, J., Montalban, J., Tintore, M., Codina, A. and Malinow, M.R. (1994 ) “Serum homocysteine levels in multiple sclerosis”, Archives of Neurology 51, 1181.
  • Schippling, S., Kontush, A., Arlt, S., Buhmann, C., Stürenburg, H.-J., Mann, U., Müller-Thomsen, T. and Beisiegel, U. (2000 ) “Increased lipoprotein oxidation in Alzheimer’s disease”, Free Radical Biology and Medicine 28, 351–360.
  • Selhub, J. (1999 ) “Homocysteine metabolism”, Annual Review of Nutrition 19, 217–246.
  • Sigal, S.H., Hall, C.A. and Antel, J.P. (1987 ) “Plasma R-binder deficiency and neurologic disease”, The New England Journal of Medicine 317, 1330–1332.
  • Spector, R. (1977 ) “Vitamin homeostasis in the central nervous system”, The New England Journal ofMedicine 296, 1393–1398.
  • Staprans, I., Rapp, J.H., Pan, X.-M., Kim, K.Y. and Feingold, K.R. (1994 ) “Oxidized lipids in the diet are a source of oxidized lipid in chylomicrons of human serum”, Arteriosclerosis and Thrombosis 14, 1900–1905.
  • Steinberg, D. (1997 ) “Low density lipoprotein oxidation and its pathobiological significance”, Journal of Biological Chemistry 272, 20963–20966.
  • Steinberg, D., Parthasarathy, S., Carew, T.E., Khoo, J.C. and Witztum, J.L. (1989 ) “Beyond Cholesterol”, The New England Journal Medicine 320, 915–924.
  • Ubbink, J.B., Vermaak, W.J.H. and Bissbort, S. (1991 ) “Rapid highperformance liquid chromatographic assay for total homocysteine levels in human serum”, Journal of Chromatogrophy 565, 441–446.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.